HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jürgen Wollenhaupt Selected Research
Jürgen Wollenhaupt Research Topics
Disease
24
Rheumatoid Arthritis
04/2022 - 06/2004
9
Psoriatic Arthritis
04/2022 - 06/2004
5
Necrosis
08/2014 - 07/2009
3
Diarrhea
04/2022 - 06/2004
3
Nausea
04/2022 - 02/2013
3
Headache (Headaches)
04/2022 - 02/2013
3
Psoriasis (Pustulosis Palmaris et Plantaris)
06/2014 - 06/2004
2
Infections
04/2022 - 07/2017
2
Nasopharyngitis
08/2020 - 02/2013
2
Ankylosing Spondylitis
11/2016 - 11/2013
2
Rheumatic Diseases (Rheumatism)
08/2014 - 02/2014
1
Dyspepsia (Indigestion)
04/2022
1
Breakthrough Infections
01/2022
1
Respiratory Tract Infections (Respiratory Tract Infection)
08/2020
1
Pain (Aches)
07/2020
1
Arthritis (Polyarthritis)
07/2020
1
Neoplasms (Cancer)
07/2017
1
Herpes Zoster
07/2017
1
Non-Radiographic Axial Spondyloarthritis
11/2016
1
Axial Spondyloarthritis
11/2016
1
Abscess
11/2013
1
Urinary Tract Infections (Urinary Tract Infection)
02/2013
1
Osteitis
04/2011
1
Synovitis
04/2011
1
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
04/2011
Drug/Important Bio-Agent (IBA)
10
tofacitinib
IBA
04/2022 - 02/2013
8
Janus Kinase Inhibitors
IBA
04/2022 - 02/2013
6
Antirheumatic Agents (DMARD)
IBA
01/2016 - 04/2011
5
golimumab
FDA Link
01/2016 - 07/2009
4
apremilast
IBA
08/2020 - 06/2014
4
Methotrexate (Mexate)
FDA Link
Generic
06/2018 - 07/2009
3
Certolizumab Pegol
FDA Link
01/2018 - 12/2012
3
Phosphodiesterase 4 Inhibitors
IBA
01/2018 - 06/2014
3
Biological Products
IBA
11/2016 - 11/2013
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2015 - 07/2009
2
ametantrone (HAQ)
IBA
07/2020 - 04/2011
2
Abatacept (Orencia)
FDA Link
06/2015 - 04/2011
2
secukinumab
IBA
02/2014 - 11/2013
2
Monoclonal Antibodies
IBA
02/2014 - 11/2013
1
Vaccines
IBA
01/2022
1
Janus Kinases
IBA
10/2020
1
C-Reactive Protein
IBA
07/2020
1
Prostaglandins A
IBA
07/2020
1
Glucocorticoids
IBA
06/2018
1
Naproxen (Naprosyn)
FDA Link
Generic
11/2016
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
11/2016
1
Infliximab (Remicade)
FDA Link
11/2016
1
Tumor Necrosis Factor Inhibitors
IBA
01/2015
1
Interleukins
IBA
02/2014
1
Cytokines
IBA
11/2013
1
Interleukin-17 (Interleukin 17)
IBA
11/2013
1
Immunologic Factors (Immunomodulators)
IBA
02/2013
1
Adalimumab (Humira)
FDA Link
12/2012
1
tocilizumab (atlizumab)
FDA Link
11/2011
1
Leflunomide (Arava)
FDA Link
Generic
06/2004
1
Alanine Transaminase (SGPT)
IBA
06/2004
1
pyrimidine
IBA
06/2004
Therapy/Procedure
7
Therapeutics
01/2017 - 01/2013
2
Aftercare (After-Treatment)
01/2015 - 07/2009
1
Biological Therapy
06/2014
1
Secondary Prevention
11/2012
1
Subcutaneous Injections
07/2009